MUC4 was found to be co-expressed with MMP9 and EGFR GBM tissue [51], and a combined high expression of MUC4/MMP9 and MUC4/MMP9/EGFR was associated with adverse outcomes [49,52]. This evidence concerns the gene EGFR and glioblastoma.